|
|
1 DNA Way
South San Francisco, CA 94080-4990 USA
phone:(650) 225-1000
fax:(650) 225-6000
|
|
| Symbol |
GENE |
| Exchange |
NYSE |
| Founded |
1976 |
| Employees |
6226 |
|
|
| www.gene.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Among the world's leading biotech companies, with multiple products on the market for serious or life-threatening medical conditions and more than 100 projects in the pipeline. |
|
| Management |
| Pascal Soriot, Chief Executive Officer; Hal Barron, M.D.Executive Vice President; Christine Castro, Senior Vice President, Corporate Relations; Ian T. Clark, Head of Global Product Strategy and Chief Marketing Officer; Stephen D. Grossman |
| |
|
|
|
|
|
|
|
| Keywords |
| biooncology avastin, herceptin, rituxan, tarceva, xeloda |
|
|
|
| Description |
|
Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. Today, Genentech is among the world's leading biotech companies, with multiple products on the market for serious or life-threatening medical conditions and more than 100 projects in the pipeline. |
|
| Products / Services |
Products for: Oncology, Immunology, Vascular Medicine, Specialty Biotherapeutics
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
